Omnicell Q3 Profit Rises - Quick Facts

(RTTNews) - Omnicell Inc. (OMCL), a provider of medication and supply management solutions to healthcare systems, reported third-quarter net income of $7.8 million, or $0.21 per share, compared to $6.9 million, or $0.20 per share, last year. Non-GAAP net income was $11.3 million or $0.31 per share, for the quarter.

On average, seven analysts polled by Thomson Reuters expected the company to report profit per share of $0.28 for the quarter. Analysts' estimates typically exclude special items.

Revenue was $94.0 million, up 11.5% from the third quarter of 2012. Analysts expected revenue of $94.96 million for the quarter.